期刊
NATURE REVIEWS DRUG DISCOVERY
卷 10, 期 9, 页码 671-684出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd3504
关键词
-
资金
- Burrough's Wellcome Fund
- Smith Family Foundation
- Starr Cancer Consortium
- Damon Runyon Cancer Research Foundation
- US National Institutes of Health
Genetic events in cancer activate signalling pathways that alter cell metabolism. Clinical evidence has linked cell metabolism with cancer outcomes. Together, these observations have raised interest in targeting metabolic enzymes for cancer therapy, but they have also raised concerns that these therapies would have unacceptable effects on normal cells. However, some of the first cancer therapies that were developed target the specific metabolic needs of cancer cells and remain effective agents in the clinic today. Research into how changes in cell metabolism promote tumour growth has accelerated in recent years. This has refocused efforts to target metabolic dependencies of cancer cells as a selective anticancer strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据